Topics: Addyi | Depression | Health Apps | Low libido | Vyleesi

Quick hits on what you’ll find in this issue.

Topics: Addyi | Alternative treatments | Bupropion | Complimentary treatments | Female hypoactive sexual desire disorder | Female Issues in Psychiatry | natural treatments | Sex Therapy | Vyleesi

There are two FDA approved treatments for low libido in women. In this article, we explain why they are not our first choice.

Topics: Behavior therapy | Brief psychotherapy | Computers in Psychiatric Practice | Free Articles | Health Apps | Therapy during medication appointment | Therapy with Med Management

Prescription apps have arrived, but Dr. Torous reminds us that the key ingredient in a mental health app is something we’ve been using all along: the therapeutic relationship.

Topics: Addyi | Female hypoactive sexual desire disorder | Female Issues in Psychiatry | Low libido | Sexual Dysfunction | Vyleesi | Women’s Issues in Psychiatry

Vyleesi is FDA approved for low libido in women, but its modest benefits and significant risks give us pause.

Topics: Antidepressants | Depression | Inflammation | Novel Medications | Treatment-Resistant Depression

A host of anti-inflammatory medicines are effective in treatment-resistant depression, particularly celecoxib.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.